Skip to content

Drug interactions

Metformin-sitagliptin + Procarbazine

Severity: Minor

Metformin-sitagliptin and Procarbazine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Procarbazine has weak MAO-inhibiting properties that may enhance insulin sensitivity and lower glucose, adding to antidiabetic drugs. The risk of significant hypoglycemia with metformin and sitagliptin is low, and the evidence is limited.

What this interaction means in plain words

Metformin-sitagliptin and Procarbazine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Metformin-sitagliptin belongs to Endocrine; Procarbazine belongs to Oncology.

Evidence level: Low

Why it happens

Weak MAO inhibition may enhance insulin action; the mechanism is not well established.

What to do

Monitor blood glucose during procarbazine therapy and adjust antidiabetic doses if glucose drops.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Metformin-sitagliptin and Procarbazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Metformin-sitagliptin with Procarbazine?

MediHelp rates the interaction as minor. Metformin-sitagliptin and Procarbazine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Procarbazine has weak MAO-inhibiting properties that may enhance insulin sensitivity and lower glucose, adding to antidiabetic drugs. The risk of significant hypoglycemia with metformin and sitagliptin is low, and the evidence is limited.

How serious is the interaction between Metformin-sitagliptin and Procarbazine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose during procarbazine therapy and adjust antidiabetic doses if glucose drops.

What other medicines interact with Metformin-sitagliptin?

MediHelp also lists interactions of Metformin-sitagliptin with, for example, Clozapine, Contrast media, Diatrizoate meglumine / diatrizoate. The full list is on the Metformin-sitagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in